AmerisourceBergen Corporation.

The US needs a more diversified pharmaceutical supply chain, but the transition may need to be more delicate than current policy proposals would suggest, FDA Commissioner Robert Califf said. Almost al

With a growing number of complex cell and gene therapies approved globally, mostly for rare disease populations, manufacturers are looking at how to make these products more accessible by delivering a

Medicare price negotiation for Part B oncology drugs will have ramifications across Medicare and commercial insurance markets because of the way that reimbursement works for physician-administered dru

Shanghai Henlius Biotech Co. Ltd. has announced the successful completion of a Phase I/II clinical trial to assess the safety and preliminary efficacy of HLX04-O (bevacizumab), a recombinant anti-VEG